Results for tag: "Psychotropic Treatment"

The psychotropic treatment market is a subset of the mental health industry that focuses on the use of psychotropic medications to treat mental health disorders. These medications are used to treat a wide range of mental health conditions, including depression, anxiety, bipolar disorder, schizophrenia, and attention-deficit/hyperactivity disorder (ADHD). The psychotropic treatment market is composed of pharmaceutical companies, medical device manufacturers, and healthcare providers. Pharmaceutical companies develop and manufacture psychotropic medications, which are then prescribed by healthcare providers. Medical device manufacturers produce devices such as transdermal patches and inhalers that are used to deliver psychotropic medications. Healthcare providers, such as psychiatrists, psychologists, and primary care physicians, are responsible for prescribing psychotropic medications to patients. Some companies in the psychotropic treatment market include Pfizer, Johnson & Johnson, Eli Lilly, GlaxoSmithKline, Novartis, and Merck. Show Less Read more